Conferences

High level Thalassaemia & SCD Healthcare Professionals Summit – 1-2 November 2019

High level Thalassaemia & SCD Healthcare Professionals Summit – 1-2 November 2019

  Intensifying its long-standing efforts to provide constructive training to both thalassaemia and other haemoglobinopathy patients and to the specialized physicians working in these fields, TIF has successfully hosted a…
Capacity, Competence & Confidence: Building the three CS for patients’ organizations – 12-13 October 2019

Capacity, Competence & Confidence: Building the three CS for patients’ organizations – 12-13 October 2019

Aiming at the continuous training of patients on issues relevant to the management of thalassaemia and other haemoglobinopathies, as well as the improvement of existing conditions and services provided for…
New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019

New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019

  Celgene Corporation, Acceleron Pharma, Sangamo Therapeutics & Agios Pharmaceuticals are expected to present new and updated data on the progress of key ongoing therapies for thalassaemia and sickle cell…
1st Cardiology Symposium on Thalassaemia

1st Cardiology Symposium on Thalassaemia

The 1st Cardiology Symposium on Thalassaemia that took place on 17-18 June 2017 in Thessaloniki Greece concluded in great success. The programme was divided into a doctors’ scientific group of…
2nd Pan-Middle East Conference on Thalassaemia & other Haemoglobinopathies

2nd Pan-Middle East Conference on Thalassaemia & other Haemoglobinopathies

We are delighted to share with you that the 2nd Pan-Middle East Conference on Thalassaemia & other Haemoglobinopathies was organized by the Thalassaemia International Federation (TIF) was completed with great…
Back to top button